Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-03-07
1991-01-08
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 514 54, 514 56, 514 62, 514801, 514953, A01N 3718, A01N 4304, A61K 3700, A61K 37715
Patent
active
049835807
ABSTRACT:
Improvement in healing of wounds of the corneal stroma is obtained by placing into the wounds a corneal mortar composition comprising an extracellular matrix material and an ophthalmologically compatible carrier material, the composition having a sufficiently high viscosity to retain it within the wound under wound-healing conditions.
REFERENCES:
patent: 4458678 (1984-07-01), Yannas et al.
patent: 4486416 (1984-12-01), Soll et al.
Kawaba et al., "Effect of Human EGF and Plasma Fibronectin on Corneal Epithelial Regeneration", Nippon Ganka Gakkai Zasshi, 88(9) 1237-44, 1984.
Nishida et al., Ophthalmology, 92(2):213-216, Feb. 1985.
Nishida et al., Arch Ophthalmol, 101:1046-1048, Jul. 1983.
Allergan Inc.
Nutter Nathan M.
LandOfFree
Methods and materials for use in corneal wound healing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and materials for use in corneal wound healing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and materials for use in corneal wound healing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-934847